Xvivo Perfusion
408 SEK -2.39%1 investor is following this company
Xvivo Perfusion is a medical technology company. The company provides solutions for lung transplantation. Examples of products that the company delivers include needles, organ storage, and cooling solutions. The products are resold to clinics and research institutes around the global market, with the largest business presence in the Nordics and Europe. The company was established via a spin-off from Vitrolife in 2012 and is headquartered in Gothenburg.
Revenue
597.54M
EBIT %
0.7 %
P/E
132.9
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
XVIVO
Daily low / high price
404.5 / 422
SEK
Market cap
12.85B SEK
Turnover
14.77M SEK
Volume
36K
Latest videos
Financial calendar
Interim report
2024-07-12
Interim report
2024-10-24
Annual report
2025-01-28
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Bure Equity | 14.3 % | 14.3 % |
Fjärde AP-fonden | 9.0 % | 9.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Conference call on Interim Report
![XVIVO, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/32e3d21b-04e6-451a-86ef-6765d2c9dea8.png)
XVIVO, Audiocast with teleconference, Q2'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
Redeye: XVIVO Q1 - Back on track
![XVIVO, Audiocast with teleconference, Q1, 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/ede0024e-8729-4786-908b-04a27ca63617.png)